JP Morgan Maintains Overweight on MasTec, Raises Price Target to $491

Benzinga Newsdesk www.benzinga.com Positive 81.2%

Neg 0% Neu 0% Pos 81.2%

JP Morgan analyst Drew Chamberlain maintains MasTec (NYSE:MTZ) with a Overweight and raises the price target from $471 to $491.